|
Name |
Citromycin
|
Molecular Formula | C13H10O5 | |
IUPAC Name* |
8,9-dihydroxy-2-methyl-5H-pyrano[3,2-c]chromen-4-one
|
|
SMILES |
CC1=CC(=O)C2=C(O1)C3=CC(=C(C=C3OC2)O)O
|
|
InChI |
InChI=1S/C13H10O5/c1-6-2-9(14)8-5-17-12-4-11(16)10(15)3-7(12)13(8)18-6/h2-4,15-16H,5H2,1H3
|
|
InChIKey |
QZZUHPUWIRSQPB-UHFFFAOYSA-N
|
|
Synonyms |
Citromycin; 37209-30-6; 8,9-dihydroxy-2-methyl-5H-pyrano[3,2-c]chromen-4-one; 3V8ST5MC5Z; 8,9-Dihydroxy-2-methyl-4H,5H-pyrano[3,2-c][1]benzopyran-4-one; 8,9-DIHYDROXY-2-METHYL-4H,5H-PYRANO[3,2-C]CHROMEN-4-ONE; 4H,5H-Pyrano(3,2-c)(1)benzopyran-4-one, 8,9-dihydroxy-2-methyl-; 4H,5H-Pyrano[3,2-c][1]benzopyran-4-one, 8,9-dihydroxy-2-methyl-; UNII-3V8ST5MC5Z; CHEMBL253329; DTXSID10190704; Q15410872
|
|
CAS | 37209-30-6 | |
PubChem CID | 3084655 | |
ChEMBL ID | CHEMBL253329 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 246.21 | ALogp: | 1.0 |
HBD: | 2 | HBA: | 5 |
Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 76.0 | Aromatic Rings: | 3 |
Heavy Atoms: | 18 | QED Weighted: | 0.698 |
Caco-2 Permeability: | -4.692 | MDCK Permeability: | 0.00001360 |
Pgp-inhibitor: | 0.004 | Pgp-substrate: | 0.297 |
Human Intestinal Absorption (HIA): | 0.012 | 20% Bioavailability (F20%): | 0.009 |
30% Bioavailability (F30%): | 0.981 |
Blood-Brain-Barrier Penetration (BBB): | 0.021 | Plasma Protein Binding (PPB): | 91.97% |
Volume Distribution (VD): | 0.611 | Fu: | 11.30% |
CYP1A2-inhibitor: | 0.956 | CYP1A2-substrate: | 0.868 |
CYP2C19-inhibitor: | 0.091 | CYP2C19-substrate: | 0.074 |
CYP2C9-inhibitor: | 0.379 | CYP2C9-substrate: | 0.616 |
CYP2D6-inhibitor: | 0.332 | CYP2D6-substrate: | 0.696 |
CYP3A4-inhibitor: | 0.13 | CYP3A4-substrate: | 0.167 |
Clearance (CL): | 10.078 | Half-life (T1/2): | 0.841 |
hERG Blockers: | 0.036 | Human Hepatotoxicity (H-HT): | 0.288 |
Drug-inuced Liver Injury (DILI): | 0.959 | AMES Toxicity: | 0.655 |
Rat Oral Acute Toxicity: | 0.351 | Maximum Recommended Daily Dose: | 0.316 |
Skin Sensitization: | 0.595 | Carcinogencity: | 0.233 |
Eye Corrosion: | 0.005 | Eye Irritation: | 0.84 |
Respiratory Toxicity: | 0.287 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000664 | 0.597 | D04AIT | 0.317 | ||||
ENC005302 | 0.493 | D0FA2O | 0.311 | ||||
ENC003772 | 0.493 | D0K8KX | 0.310 | ||||
ENC001622 | 0.429 | D07MGA | 0.306 | ||||
ENC001518 | 0.406 | D0G4KG | 0.288 | ||||
ENC002517 | 0.403 | D06GCK | 0.266 | ||||
ENC004203 | 0.400 | D02FCQ | 0.253 | ||||
ENC001542 | 0.397 | D02PMO | 0.236 | ||||
ENC004676 | 0.397 | D0Z4XW | 0.234 | ||||
ENC005370 | 0.397 | D06TJJ | 0.232 |